Search Within

Michael Morris

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (1)
  3. Review (1)
Groups
  1. Advanced Practice Providers (8)
  2. Department of Medicine (8)
  3. Genitourinary Oncology Service (8)
  4. Nursing (8)
  5. Solid Tumor Oncology Division (8)
  6. Hematologic Malignancies, Division of (7)

More Groups

People
  1. Gabrielle Arauz (7)
  2. Howard Scher (7)
  3. Susan Slovin (7)
  4. Dana Rathkopf (4)
  5. Daniel Danila (4)
  6. Tracy Smart-Curley (4)

More People

Years
  1. 2024 (1)
  2. 2020 (1)
  3. 2017 (1)
  4. 2016 (1)
  5. 2012 (2)
  6. 2011 (1)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Cancer (1)
  3. Journal of the National Cancer Institute - Monographs (1)
Publishers
  1. American Society of Clinical Oncology (6)
  2. Oxford University Press (1)
  3. Wiley Blackwell (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Transforming patient-centered cancer care using telehealth: The MATCHES center
    Review

    Bange, E. M.; Daly, R. M.; Lipitz-Snyderman, A.; Kuperman, G.; Polubriaginof, F. C. G.; Liebertz, C.; Doshi, S. D.; Stevanovic, K.; Chan, K.; Bernal, C.; more...
    Journal of the National Cancer Institute - Monographs (2024)

    Fulltext@MSK | Save
  • Evaluation of immune-related adverse events (irAE): Utilizing the patient-reported outcomes of the common terminology criteria for adverse events (PRO-CTCAE) in a phase II study of ipilimumab (ipi) in men with castration-sensitive prostate cancer (CSPC)
    Meeting Abstract

    Vargas Pivato de Almeida, D.; Anderson, J.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Abida, W.; Dayan, E. S.; Curley, T.; Arauz, G.; Baser, R. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Halabi, S.; Carbone, E.; Fernandez, C.; Chen, Y.; Autio, K. A.; Rathkopf, D. E.; Kampel, L.; Morris, M. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Carbone, E.; Showunmi, A.; Hullings, M.; Morris, M. J.; Autio, K. A.; Kampel, L. J.; Molina, A. M.; Chen, Y.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase I study of the androgen signaling inhibitor ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Rathkopf, D. E.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Steinbrecher, J. E.; Arauz, G.; Curley, T.; Rix, P. J.; Maneval, E. C.; Chen, I.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase I/II safety and pharmacokinetic (PK) study of ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC): Phase I results of a Prostate Cancer Clinical Trials Consortium study
    Meeting Abstract

    Rathkopf, D. E.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Steinbrecher, J. E.; Arauz, G.; Rix, P. J.; Maneval, E. C.; Chen, I.; Fox, J. J.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody cixutumumab (cix) plus mTOR inhibitor temsirolimus (tem) in metastatic castration-resistant prostate cancer (mCRPC): Results of a phase I pilot study
    Meeting Abstract

    Rathkopf, D. E.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Borwick, L. S.; Momen, L.; Curley, T.; Arauz, G.; Larson, S. M.; Fleisher, M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Methylphenidate for fatigue in ambulatory men with prostate cancer
    Journal Article

    Roth, A. J.; Nelson, C.; Rosenfeld, B.; Scher, H.; Slovin, S.; Morris, M.; O'Shea, N.; Arauz, G.; Breitbart, W.
    Cancer (2010)

    Fulltext@MSK | Save